Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-16 4:42 pm Purchase | 13G | ORAMED PHARMACEUTICALS INC. ORMP | BML Investment Partners L.P. | 2,048,634 5.000% | 2,048,634 (New Position) | View |
| 2024-03-22 9:30 pm Purchase | 13D | ORAMED PHARMACEUTICALS INC. ORMP | KIDRON NADAV | 2,343,919 5.700% | 1,000,473 (+74.47%) | View |
| 2021-09-02 4:49 pm Sale | 13D | ORAMED PHARMACEUTICALS INC. ORMP | KIDRON NADAV | 1,343,446 4.100% | -1,288,614 (-48.96%) | View |
| 2021-02-09 3:52 pm Purchase | 13G | ORAMED PHARMACEUTICALS INC. ORMP | Slager David Mark | 1,344,123 5.040% | 27,800 (+2.11%) | View |
| 2020-02-14 11:54 am Unchanged | 13G | ORAMED PHARMACEUTICALS INC. ORMP | Altium Capital Management LP | 972,000 4.990% | 0 (Unchanged) | View |
| 2020-02-11 11:46 am Sale | 13G | ORAMED PHARMACEUTICALS INC. ORMP | Slager David Mark | 1,316,323 7.400% | -11,293 (-0.85%) | View |
| 2020-01-21 2:40 pm Sale | 13G | ORAMED PHARMACEUTICALS INC. ORMP | SABBY MANAGEMENT LLC | 885,015 11.000% | -48,035 (-5.15%) | View |